HER2‐positive metastatic, parotid salivary duct carcinoma treated with a trastuzumab/pertuzumab‐based chemotherapy: A case report

Abstract This case highlights the rare entity, salivary duct carcinoma (SDC), which is difficult to diagnose and manage. It is the first published case of a metastatic, HER2‐positive parotid SDC successfully treated by a dual anti‐HER2 treatment associated to a chemotherapy.

Detalhes bibliográficos

Principais autores:	Raffaele Longo, Pierre‐Olivier Legros, Marouane Talbi, Marc Wagner, Elena‐Adinisia Paraschiv, Marco Campitiello, Francesca Plastino, Antonio Rozzi
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wiley 2020-12-01
coleção:	Clinical Case Reports
Assuntos:	duct carcinoma HER2 parotid pertuzumab trastuzumab
Acesso em linha:	https://doi.org/10.1002/ccr3.3209
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!